2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Print

Symposium

[SY24] Symposium 24　Developments in the treatment of soft tissue sarcoma
【SI】【E】

Sat. Feb 19, 2022 10:00 AM - 11:30 AM Room 3 (Annex 2, 1F, Kyoto International Conference Center)

Chair：Shunji Takahashi（Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research），Suzanne George（Department of Medical Oncology, Dana-Farber Cancer Institute）

[SY24-3] A phase II study evaluating the clinical efficacy of an MDM2 inhibitor, milademetan, in patients with intimal sarcoma (NCCH1806/MK004)

○Kazuki Sudo1,2, Toshio Shimizu2, Kan Yonemori1,2, Takafumi Koyama2, Naoko Matsui3, Masahisa Kamikura3, Sawako Tomatsuri3, Yuki Kojima1, Hitomi Okuma1, Tatsunori Shimoi1, Emi Noguchi1, Akihiko Hirakawa4, Ryo Sadachi3, Okita Natsuko3, Kenichi Nakamura3, Noboru Yamamoto2, Yasuhiro Fujiwara1,5 (1.Department of Medical Oncology, National Cancer Center Hospital, 2.Department of Experimental Therapeutics, National Cancer Center Hospital, 3.Clinical Research Support Office, National Cancer Center Hospital, 4.Clinical Biostatistics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 5.Pharmaceutical and Medical Devices Agency)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password